A causal inference framework for leveraging external controls in hybrid trials
Biometrics · 2024
DOI: 10.1093/biomtc/ujae095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, 2024. Verfasst von Michael Valancius und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States. Hauptthemen laut MEDLINE: Causality, Computer Simulation, Randomized Controlled Trials as Topic, Models, Statistical. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, U.S. Department of Health and Human Services, FDA.
Abstract (Originalsprache)
We consider the challenges associated with causal inference in settings where data from a randomized trial are augmented with control data from an external source to improve efficiency in estimating the average treatment effect (ATE). This question is motivated by the SUNFISH trial, which investigated the effect of risdiplam on motor function in patients with spinal muscular atrophy. While the original analysis used only data generated by the trial, we explore an alternative analysis incorporating external controls from the placebo arm of a historical trial. We cast the setting into a formal causal inference framework and show how these designs are characterized by a lack of full randomization to treatment and heightened dependency on modeling. To address this, we outline sufficient causal assumptions about the exchangeability between the internal and external controls to identify the ATE and establish a connection with novel graphical criteria. Furthermore, we propose estimators, review efficiency bounds, develop an approach for efficient doubly robust estimation even when unknown nuisance models are estimated with flexible machine learning methods, suggest model diagnostics, and demonstrate finite-sample performance of the methods through a simulation study. The ideas and methods are illustrated through their application to the SUNFISH trial, where we find that external controls can increase the efficiency of treatment effect estimation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
- Product Development Data Sciences, Genentech, South San Francisco, CA 94080, United States.
- Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
ORCID-Profile: Michael R Kosorok
Förderung
- NIH HHS
- U.S. Department of Health and Human Services
- FDA
- NIAID NIH HHS
- FDA HHS
- Food and Drug Administration
- NIH
Zitieren
APA
Valancius, M., Pang, H., Zhu, J., Cole, S. R., Jonsson Funk, M., & Kosorok, M. R. (2024). A causal inference framework for leveraging external controls in hybrid trials. Biometrics. https://doi.org/10.1093/biomtc/ujae095
Vancouver
Valancius M, Pang H, Zhu J, Cole SR, Jonsson Funk M, Kosorok MR. A causal inference framework for leveraging external controls in hybrid trials. Biometrics. 2024. doi:10.1093/biomtc/ujae095
BibTeX
@article{Valancius2024,
author = {Valancius, Michael and Pang, Herbert and Zhu, Jiawen and Cole, Stephen R and Jonsson Funk, Michele and Kosorok, Michael R},
title = {A causal inference framework for leveraging external controls in hybrid trials},
journal = {Biometrics},
year = {2024},
doi = {10.1093/biomtc/ujae095}
}
EUVIMED